Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: MCRB) | Delayed: 2.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $44.51 | |||
| Open | $2.30 | 52 Week Low | $8.05 | |||
| Day High | $2.30 | P/E | N/A | |||
| Day Low | $2.30 | EPS | $0.00 | |||
| Volume | 7 | |||||
